These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24075186)

  • 1. Mutations in NALCN cause an autosomal-recessive syndrome with severe hypotonia, speech impairment, and cognitive delay.
    Al-Sayed MD; Al-Zaidan H; Albakheet A; Hakami H; Kenana R; Al-Yafee Y; Al-Dosary M; Qari A; Al-Sheddi T; Al-Muheiza M; Al-Qubbaj W; Lakmache Y; Al-Hindi H; Ghaziuddin M; Colak D; Kaya N
    Am J Hum Genet; 2013 Oct; 93(4):721-6. PubMed ID: 24075186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UNC80 mutation causes a syndrome of hypotonia, severe intellectual disability, dyskinesia and dysmorphism, similar to that caused by mutations in its interacting cation channel NALCN.
    Perez Y; Kadir R; Volodarsky M; Noyman I; Flusser H; Shorer Z; Gradstein L; Birnbaum RY; Birk OS
    J Med Genet; 2016 Jun; 53(6):397-402. PubMed ID: 26545877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo mutations in NALCN cause a syndrome characterized by congenital contractures of the limbs and face, hypotonia, and developmental delay.
    Chong JX; McMillin MJ; Shively KM; Beck AE; Marvin CT; Armenteros JR; Buckingham KJ; Nkinsi NT; Boyle EA; Berry MN; Bocian M; Foulds N; Uzielli ML; Haldeman-Englert C; Hennekam RC; Kaplan P; Kline AD; Mercer CL; Nowaczyk MJ; Klein Wassink-Ruiter JS; McPherson EW; Moreno RA; Scheuerle AE; Shashi V; Stevens CA; Carey JC; Monteil A; Lory P; Tabor HK; Smith JD; Shendure J; Nickerson DA; ; Bamshad MJ
    Am J Hum Genet; 2015 Mar; 96(3):462-73. PubMed ID: 25683120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo missense mutations in NALCN cause developmental and intellectual impairment with hypotonia.
    Fukai R; Saitsu H; Okamoto N; Sakai Y; Fattal-Valevski A; Masaaki S; Kitai Y; Torio M; Kojima-Ishii K; Ihara K; Chernuha V; Nakashima M; Miyatake S; Tanaka F; Miyake N; Matsumoto N
    J Hum Genet; 2016 May; 61(5):451-5. PubMed ID: 26763878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of CLIFAHDD and IHPRF pathogenic variants of the NALCN channel in neuronal cells reveals both gain- and loss-of-function properties.
    Bouasse M; Impheng H; Servant Z; Lory P; Monteil A
    Sci Rep; 2019 Aug; 9(1):11791. PubMed ID: 31409833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic mutations in NALCN: Expanding the genotypic and phenotypic spectra of IHPRF1.
    Takenouchi T; Inaba M; Uehara T; Takahashi T; Kosaki K; Mizuno S
    Am J Med Genet A; 2018 Feb; 176(2):431-437. PubMed ID: 29168298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel NALCN biallelic truncating mutations in siblings with IHPRF1 syndrome.
    Angius A; Cossu S; Uva P; Oppo M; Onano S; Persico I; Fotia G; Atzeni R; Cuccuru G; Asunis M; Cucca F; Pruna D; Crisponi L
    Clin Genet; 2018 Jun; 93(6):1245-1247. PubMed ID: 29399786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A homozygous truncating NALCN variant in two Afro-Caribbean siblings with hypotonia and dolichocephaly.
    Ope O; Bhoj EJ; Nelson B; Li D; Hakonarson H; Sobering AK
    Am J Med Genet A; 2020 Aug; 182(8):1877-1880. PubMed ID: 32618095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodic breathing in patients with NALCN mutations.
    Bourque DK; Dyment DA; MacLusky I; Kernohan KD; ; McMillan HJ
    J Hum Genet; 2018 Oct; 63(10):1093-1096. PubMed ID: 29968795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NALCN Dysfunction as a Cause of Disordered Respiratory Rhythm With Central Apnea.
    Campbell J; FitzPatrick DR; Azam T; Gibson NA; Somerville L; Joss SK; ; Urquhart DS
    Pediatrics; 2018 Apr; 141(Suppl 5):S485-S490. PubMed ID: 29610177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic Mutations in UNC80 Cause Persistent Hypotonia, Encephalopathy, Growth Retardation, and Severe Intellectual Disability.
    Stray-Pedersen A; Cobben JM; Prescott TE; Lee S; Cang C; Aranda K; Ahmed S; Alders M; Gerstner T; Aslaksen K; Tétreault M; Qin W; Hartley T; Jhangiani SN; Muzny DM; Tarailo-Graovac M; van Karnebeek CD; ; ; Lupski JR; Ren D; Yoon G
    Am J Hum Genet; 2016 Jan; 98(1):202-9. PubMed ID: 26708751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in components of the NALCN-UNC80-UNC79 ion channel complex cause a broad clinical phenotype (NALCN channelopathies).
    Bramswig NC; Bertoli-Avella AM; Albrecht B; Al Aqeel AI; Alhashem A; Al-Sannaa N; Bah M; Bröhl K; Depienne C; Dorison N; Doummar D; Ehmke N; Elbendary HM; Gorokhova S; Héron D; Horn D; James K; Keren B; Kuechler A; Ismail S; Issa MY; Marey I; Mayer M; McEvoy-Venneri J; Megarbane A; Mignot C; Mohamed S; Nava C; Philip N; Ravix C; Rolfs A; Sadek AA; Segebrecht L; Stanley V; Trautman C; Valence S; Villard L; Wieland T; Engels H; Strom TM; Zaki MS; Gleeson JG; Lüdecke HJ; Bauer P; Wieczorek D
    Hum Genet; 2018 Sep; 137(9):753-768. PubMed ID: 30167850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel homozygous splice site mutation in NALCN identified in siblings with cachexia, strabismus, severe intellectual disability, epilepsy and abnormal respiratory rhythm.
    Gal M; Magen D; Zahran Y; Ravid S; Eran A; Khayat M; Gafni C; Levanon EY; Mandel H
    Eur J Med Genet; 2016 Apr; 59(4):204-9. PubMed ID: 26923739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel NALCN variant linked to temporal lobe epilepsy.
    Nguyen E; Tétreault M; Toffa DH; Cossette P; Samarut É; Nguyen DK
    Am J Med Genet A; 2023 Jul; 191(7):1942-1947. PubMed ID: 37046053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NALCN channelopathies: Distinguishing gain-of-function and loss-of-function mutations.
    Bend EG; Si Y; Stevenson DA; Bayrak-Toydemir P; Newcomb TM; Jorgensen EM; Swoboda KJ
    Neurology; 2016 Sep; 87(11):1131-9. PubMed ID: 27558372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel homozygous UNC80 variant in a child with infantile hypotonia with psychomotor retardation and characteristic facies-2 (IHPRF2).
    Obeid T; Hamzeh AR; Saif F; Nair P; Mohamed M; Al-Ali MT; Bastaki F
    Metab Brain Dis; 2018 Jun; 33(3):869-873. PubMed ID: 29430593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional de novo missense genetic variants in NALCN associated with CLIFAHDD syndrome.
    Vivero M; Cho MT; Begtrup A; Wentzensen IM; Walsh L; Payne K; Zarate YA; Bosanko K; Schaefer GB; DeBrosse S; Pollack L; Mason K; Retterer K; DeWard S; Juusola J; Chung WK
    Clin Genet; 2017 Jun; 91(6):929-931. PubMed ID: 28133733
    [No Abstract]   [Full Text] [Related]  

  • 19. A Gain-of-Function Mutation in NALCN in a Child with Intellectual Disability, Ataxia, and Arthrogryposis.
    Aoyagi K; Rossignol E; Hamdan FF; Mulcahy B; Xie L; Nagamatsu S; Rouleau GA; Zhen M; Michaud JL
    Hum Mutat; 2015 Aug; 36(8):753-7. PubMed ID: 25864427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.